EU-AIMS Longitudinal European Autism Project (LEAP)

The Longitudinal European Autism Project is part of a European multi-centre study which will include approximately 420 participants with ASC from 6-30 years and 325 control participants. The same study protocol will be carried out simultaneously at seven study sites across Europe. This includes Institute of Psychiatry, King’s College London, Autism Research Centre, University of Cambridge, University Medical Centre Utrecht, Radboud University Medical Centre Nijmegen, Central Institute of Mental Health, Germany, University Campus Bio-medico, Rome Italy and the Karolinska Institute, Stockholm. Each participant will be seen at two time-points within a 12-24 months period. Each assessment wave includes 1-2 Institute visits. Participants will be asked to take part in clinical assessments, cognitive tasks, Eye tracking and a structural and functional MRI scan. Blood, urine and saliva samples will be taken. This study aims to identify biomarkers with an established link to heritable risk for autism. Visit http://www.eu-aims.eu for a full report of progress on this large program of research.